TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY
SUBCHAPTER b: RADIATION PROTECTION
PART 335 MEDICAL USE OF RADIOACTIVE MATERIAL
SECTION 335.9030 TRAINING FOR UPTAKE, DILUTION OR EXCRETION STUDIES


 

Section 335.9030  Training for Uptake, Dilution or Excretion Studies

 

Except as provided in Section 335.9160, a licensee shall require the authorized user of unsealed radioactive material for the uses authorized under Section 335.3010 not requiring a written directive to be a physician who:

 

a)         Is certified by a medical specialty board whose certification process has been recognized by the Agency, the U.S. Nuclear Regulatory Commission, or an Agreement State.  To have its certification process recognized, a specialty board shall require all candidates for certification to meet the following requirements:

 

1)         Complete 60 hours of training and experience in basic radionuclide handling techniques and radiation safety applicable to the medical use of unsealed radioactive material for uptake, dilution and excretion studies as described in subsections (c)(1) and (2); and

 

2)         Pass an examination administered by diplomates of the specialty board, that evaluates knowledge and competence in radiation safety, radionuclide handling and quality control; or

 

b)         Is an authorized user who meets the requirements of Section 335.9040 or 335.9050 or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements; or

 

c)         Has successfully completed a structured educational program consisting of:

 

1)         60 hours of training and experience, including a minimum of 8 hours of classroom and laboratory training, in basic radionuclide handling techniques applicable to the medical use of unsealed radioactive material for uptake, dilution and excretion studies.  The classroom and laboratory training shall include, at a minimum: 

 

A)        Radiation physics and instrumentation;

 

B)        Radiation protection;

 

C)        Mathematics pertaining to the use and measurement of radioactivity;

 

D)        Chemistry of radioactive material for medical use;

 

E)        Radiation biology; and

 

2)         Work experience under the supervision of an authorized user who meets the requirements in this Section, Section 335.9040, 335.9050 or 335.9160, or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements involving:

 

A)        Ordering, receiving, and unpacking radioactive materials safely and performing the related radiation monitoring;

 

B)        Performing quality control procedures on instruments used to determine the activity of dosages and performing checks for proper operation of survey instruments;

 

C)        Calculating, measuring and safely preparing patient or human research subject dosages;

 

D)        Using administrative controls to prevent a medical event involving the use of unsealed radioactive material;

 

E)        Using procedures to contain spilled radioactive material safely and using proper decontamination procedures; and

 

F)         Administering dosages of radioactive drugs to patients or human research subjects; and

 

3)         Has obtained written attestation that the individual has satisfactorily completed the requirements in subsection (c) and is able to independently fulfill the radiation safety-related duties as an authorized user for the medical uses authorized by Section 335.3010.  The attestation shall be obtained from either:

 

A)        A preceptor authorized user who meets the requirements in this Section or Section 335.9040, 335.9050 or 335.9160, or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements; or

 

B)        A residency program director who affirms in writing that the attestation represents the consensus of the residency program faculty where at least one faculty member is an authorized user who meets the requirements in this Section, Sections 335.9040, 335.9050 or 335.9160, or equivalent Agreement State requirements, and concurs with the attestation provided by the residency program director.  The residency training program shall be approved by the Residency Review Committee of the Accreditation Council for Graduate Medical Education, the Royal College of Physicians and Surgeons of Canada, or the Council on Postdoctoral Training of the American Osteopathic Association and shall include training and work experience specified in subsections (c)(1) and (c)(2). 

 

AGENCY NOTE:  Specialty boards whose certification processes have been recognized by the Agency, the U.S. Nuclear Regulatory Commission or an Agreement State will be posted on the NRC's website. 

 

(Source:  Amended at 46 Ill. Reg. 966, effective December 21, 2021)